Glaukos Cash Flow Statement
NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD
165.69+4.40 (+2.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Glaukos free cash flow
In fiscal 2025, Glaukos generated -$14.8 million of operating cash flow and spent $7.7 million on capital expenditures. That left free cash flow of -$22.5 million, a free-cash-flow margin of -4.4% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Glaukos cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -187.69M | -146.37M | -134.66M | -99.19M | -49.59M | -120.35M | 15.42M | -12.95M | -92.00K | 4.52M |
| Net Income growth (YoY) | — | — | — | — | — | -880.26% | — | — | -102.03% | — |
| Depreciation & Amortization | 38.09M | 35.65M | 33.65M | 31.58M | 29.66M | 29.38M | 6.31M | 6.26M | 5.48M | 4.72M |
| Stock-Based Compensation | 63.22M | 50.21M | 43.53M | 38.56M | 30.15M | 46.48M | 36.39M | 25.70M | 17.59M | 8.79M |
| Change in Working Capital | -41.90M | -41.30M | -7.73M | -11.40M | 6.45M | 1.52M | -5.80M | -2.03M | 3.40M | -4.63M |
| Operating Cash Flow | -14.79M | -61.32M | -57.76M | -33.08M | 24.71M | -22.99M | -369.00K | 18.86M | 26.09M | 12.31M |
| Capital Expenditures | -7.67M | -6.30M | -20.25M | -30.27M | -47.78M | -6.93M | -4.72M | -10.31M | -6.31M | -6.28M |
| Investing Cash Flow | -77.61M | 47.83M | 14.10M | 44.78M | -58.23M | -205.06M | 43.43M | -26.40M | -12.39M | -26.12M |
| Debt Issued | — | — | — | — | — | 287.50M | — | — | — | — |
| Financing Cash Flow | 11.89M | 91.54M | 15.04M | 6.25M | 39.26M | 262.54M | -9.64M | 21.58M | 4.67M | -1.64M |
| Net Change in Cash | -79.71M | 75.04M | -27.28M | 16.48M | 3.96M | 34.41M | 33.16M | 14.09M | 17.93M | -15.08M |
| Free Cash Flow | -22.45M | -67.62M | -78.01M | -63.35M | -23.08M | -29.92M | -5.09M | 8.55M | 19.78M | 6.03M |
This table shows 10 annual periods of Glaukos's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GKOS's reporting calendar. What is a cash flow statement?